Automated Breast Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Product, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Automated Breast Ultrasound Market size stood at USD 2.6 billion in 2026 and is predicted to grow at a 12.92% CAGR from 2027 to 2036, exceeding USD 8.76 billion by 2036. The industry revenue for 2027 is calculated at USD 2.88 billion.
Get more details on this report
Request Free Sample ReportAutomated Breast Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to advanced breast imaging infrastructure, widespread diagnostic system availability, and routine integration of automated ultrasound into established clinical screening workflows.
- Asia Pacific is expanding at 15.01% CAGR, driven by broader access to imaging systems and increasing adoption of scalable, workflow-efficient breast screening technologies across healthcare facilities.
Segment Momentum
- ABUS leads with 61.01% share due to strong clinical familiarity, integration into diagnostic workflows, and standardized imaging that reduces operator dependence in high-volume breast screening environments.
- Automated Breast Volume Scanner is growing faster due to demand for more comprehensive volumetric breast imaging, offering detailed tissue visualization and aligning with efficient, structured diagnostic interpretation needs.
Market Expansion Drivers
- Rising global breast cancer prevalence increasing demand for early-stage diagnostic imaging solutions.
- Government awareness programs and cancer screening initiatives accelerating automated ultrasound adoption.
- Advancements in wearable and AI-enabled breast imaging technologies improving diagnostic accuracy.
Leading Market Participants
- Leading players in the automated breast ultrasound market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Hologic, Inc. (United States), Delphinus Medical Technologies, Inc. (United States), SuperSonic Imagine SA (France), TELEMED Medical Systems S.r.l. (Italy), Samsung Medison Co., Ltd. (South Korea).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.6 billion
- 2027 Estimated Market Size: USD 2.88 billion.
- Projected Market Size: USD 8.76 billion by 2036
- Growth Forecast: 12.92% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Automated Breast Ultrasound (ABUS) (Product) | Hospital (End Use)
- Emerging Opportunity Segment: Automated Breast Volume Scanner (Product) | Diagnostics Imaging Laboratories (End Use)
Market Growth Drivers and Industry Trends
Rising global breast cancer prevalence increasing demand for early-stage diagnostic imaging solutions
The rising incidence of breast cancer is creating greater demand for accessible and effective diagnostic imaging, and the automated breast ultrasound market will benefit from the growing emphasis on detecting abnormalities at earlier stages. Automated ultrasound systems can support breast examination by providing consistent imaging of breast tissue and helping identify lesions that may require further clinical evaluation, particularly in screening environments where imaging efficiency and reproducibility are important. Increasing awareness of the benefits associated with early diagnosis is also encouraging healthcare providers to strengthen breast cancer screening pathways, while the need for complementary imaging options can support broader utilization of automated ultrasound technologies among diagnostic centers and hospitals.
Government awareness programs and cancer screening initiatives accelerating automated ultrasound adoption
Public health campaigns and organized cancer screening initiatives are expanding awareness of routine breast examinations and encouraging healthcare systems to improve access to diagnostic services. Within the automated breast ultrasound market, these initiatives can accelerate adoption by increasing screening volumes and creating demand for imaging technologies capable of supporting standardized and efficient examinations. Government-backed programs can also encourage investments in diagnostic infrastructure, particularly where healthcare authorities are seeking to improve early detection and extend screening services to underserved populations. Greater patient participation in screening programs increases the need for imaging capacity and can encourage healthcare facilities to incorporate automated ultrasound systems into established breast cancer diagnostic workflows.
Advancements in wearable and AI-enabled breast imaging technologies improving diagnostic accuracy
Technological innovation is enhancing the capabilities of breast imaging through the integration of artificial intelligence, advanced sensors, and increasingly flexible imaging approaches. The automated breast ultrasound market is gaining from these developments as AI-enabled technologies can assist clinicians in interpreting images, identifying suspicious patterns, and reducing variability in image assessment. Wearable and compact imaging concepts may further support convenient monitoring and broaden the settings in which breast imaging can be performed, while automated image acquisition and intelligent analysis can improve workflow efficiency. These capabilities are particularly relevant for healthcare providers seeking diagnostic solutions that combine improved image interpretation with easier integration into modern screening and clinical environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global breast cancer prevalence increasing demand for early-stage diagnostic imaging solutions | 2.50% | High | North America, Asia Pacific | High | Near Term |
| Government awareness programs and cancer screening initiatives accelerating automated ultrasound adoption | 2.10% | High | Asia Pacific, Europe | High | Mid Term |
| Advancements in wearable and AI-enabled breast imaging technologies improving diagnostic accuracy | 1.80% | High | North America, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the automated breast ultrasound market in 2026, supported by advanced breast imaging infrastructure, widespread access to specialized diagnostic services, and strong emphasis on early detection of breast abnormalities. Healthcare providers are increasingly adopting automated ultrasound technologies to complement conventional imaging, particularly where improved breast tissue visualization is clinically valuable. Established reimbursement frameworks, growing awareness of breast cancer screening, and continued investment in diagnostic imaging capabilities further reinforce regional demand for automated and standardized ultrasound solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, increasing awareness of breast cancer screening, and improving access to advanced diagnostic technologies. Rising healthcare expenditure and the modernization of hospitals and diagnostic centers are creating favorable conditions for the adoption of automated imaging systems. The growing need for efficient screening approaches in densely populated markets, combined with increasing clinical focus on earlier diagnosis, is expected to support broader utilization of automated breast ultrasound technologies across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Imaging Workflow OptimizationGermany is adopting automated breast ultrasound technologies to improve consistency and efficiency in breast imaging services. Healthcare institutions in Germany are evaluating systems that reduce operator dependency while supporting standardized diagnostic pathways.
France 🇫🇷
Structured Screening SupportFrance is focusing on technologies that complement established breast screening pathways and improve examination consistency. French healthcare providers are considering automated breast ultrasound solutions that enhance diagnostic confidence and streamline imaging workflows.
Italy 🇮🇹
Hospital Imaging ModernizationItaly's automated breast ultrasound market is supported by ongoing modernization of hospital imaging capabilities. Healthcare facilities in Italy are prioritizing systems that improve examination standardization and provide additional imaging options for complex breast assessments.
Japan 🇯🇵
Precision Diagnostic IntegrationJapan emphasizes advanced imaging technologies that enhance diagnostic precision and support early cancer detection initiatives. Hospitals in Japan are incorporating automated breast ultrasound into broader imaging protocols, particularly where detailed breast assessments are required.
South Korea 🇰🇷
Technology-Enabled Screening ExpansionSouth Korea is investing in advanced diagnostic imaging platforms that improve patient access and screening efficiency. Medical centers in South Korea are increasingly evaluating automated breast ultrasound systems as part of comprehensive breast health programs.
United States 🇺🇸
Supplemental Screening AdoptionThe U.S. market for automated breast ultrasound is driven by growing use of adjunct screening technologies for women with dense breast tissue. Healthcare providers in the U.S. are integrating automated systems to improve workflow efficiency and support earlier detection strategies.
Segment Leadership and Growth Trends
Automated Breast Ultrasound Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Automated Breast Ultrasound (ABUS) (Largest Segment) vs Automated Breast Volume Scanner (Fastest-Growing Segment)
Automated breast ultrasound (ABUS) led the automated breast ultrasound market in 2026, capturing a 61.01% share, supported by its ability to provide standardized breast imaging while reducing dependence on continuous manual probe manipulation. Its suitability for supplemental breast examination, particularly where conventional imaging may have limitations, strengthens its role in diagnostic workflows. Automated acquisition and reproducible imaging also support efficient interpretation and integration into structured breast-screening practices.
The automated breast volume scanner segment is gaining momentum as healthcare providers seek volumetric breast imaging solutions that can improve visualization and support consistent examination workflows. Its ability to capture broader three-dimensional breast information can complement conventional imaging approaches, while growing emphasis on earlier detection and more comprehensive breast assessment is supporting adoption among diagnostic facilities.
End Use Segment Analysis: Hospital (Largest Segment) vs Diagnostics Imaging Laboratories (Fastest-Growing Segment)
Hospitals accounted for the largest share of the automated breast ultrasound market in 2026, representing 51.3%, due to their comprehensive diagnostic infrastructure, multidisciplinary clinical teams, and ability to manage patients across screening, diagnosis, treatment planning, and follow-up care. Automated breast ultrasound systems can be incorporated into established imaging departments, allowing hospitals to expand diagnostic capabilities while supporting coordinated breast-care pathways.
Diagnostics imaging laboratories are emerging as a rapidly expanding end-use setting as imaging services increasingly emphasize specialized, efficient, and patient-focused diagnostic workflows. These facilities can deploy automated ultrasound technologies to support standardized examinations and accommodate growing demand for breast imaging services, while their focus on diagnostic throughput and specialized imaging expertise strengthens the appeal of automated systems.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Automated Breast Volume Scanner, Automated Breast Ultrasound (ABUS) | Automated Breast Ultrasound (ABUS) | Automated Breast Volume Scanner |
| End Use | Hospital, Diagnostics Imaging Laboratories, Others | Hospital | Diagnostics Imaging Laboratories |
Competitive Landscape and Market Positioning
Key companies in the automated breast ultrasound market:
1. GE HealthCare Technologies Inc. (United States)
2. Koninklijke Philips N.V. (Netherlands)
3. Siemens Healthineers AG (Germany)
4. Canon Medical Systems Corporation (Japan)
5. Hologic Inc. (United States)
6. Delphinus Medical Technologies Inc. (United States)
7. SuperSonic Imagine SA (France)
8. TELEMED Medical Systems S.r.l. (Italy)
9. Samsung Medison Co. Ltd. (South Korea)
Advancements in diagnostic imaging technologies are strengthening the automated breast ultrasound market, with growing emphasis on improved image quality, workflow efficiency, and early disease detection. Regulatory support for advanced screening technologies is further encouraging wider clinical adoption and continued product innovation.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Hologic Inc. (United States) | |||||||
| Delphinus Medical Technologies Inc. (United States) | |||||||
| SuperSonic Imagine SA (France) | |||||||
| TELEMED Medical Systems S.r.l. (Italy) | |||||||
| Samsung Medison Co. Ltd. (South Korea). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| EndoCure | Jan-26 | EndoCure has developed a proprietary robotic imaging platform capable of generating high-density 3D images with precision surpassing conventional MRI technology. This innovation is strategically positioned to enhance diagnostic accuracy for oncology applications, representing a significant technological advancement in the automated breast imaging and diagnostic landscape. |
| Athens-Limestone Hospital | Oct-25 | Athens-Limestone Hospital deployed an FDA-approved automated breast ultrasound system to improve diagnostic efficacy for patients with dense breast tissue. This installation highlights the operational shift toward incorporating automated screening protocols in regional healthcare settings to increase the detection sensitivity for small-scale cancers and improve patient outcomes. |
| GE HealthCare | Mar-25 | GE HealthCare launched the Invenia ABUS Premium, an AI-enabled automated breast ultrasound system designed to optimize supplemental screening workflows. By integrating advanced imaging and automation, the system aims to improve diagnostic performance and operational efficiency in breast cancer detection, strengthening the company’s competitive position in the automated ultrasound market. |
| Hospital Universiti Sains Malaysia | Oct-24 | Hospital Universiti Sains Malaysia integrated the Invenia ABUS 2.0 system into its diagnostic suite, marking a strategic expansion of automated breast imaging technology in the region. This adoption enhances the facility's clinical capabilities for breast cancer detection and reflects the increasing global penetration of automated ultrasound systems in hospital networks. |
| Delphinus Medical Technologies, Inc. | Jul-24 | Delphinus Medical Technologies expanded the market footprint of its SoftVue 3D whole-breast ultrasound tomography system through a clinical implementation at West Jefferson Medical Center. This deployment demonstrates the ongoing commercial adoption of specialized breast ultrasound technology aimed at improving lesion detection in patients with dense breast tissue. |
| iSono Health | May-22 | iSono Health secured FDA clearance for its ATUSA system, a portable, automated breast imaging platform. This regulatory milestone enables the company to commercialize a specialized technology designed to improve accessibility and diagnostic outcomes in breast ultrasound screening, marking a significant entry of a new, distinct imaging capability into the market. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Automated Breast Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Application | Breast Cancer Screening, Diagnostic Evaluation, Supplemental Imaging, High-Risk Surveillance |
| Healthcare Facility Ownership | Public/Government Facilities, Private Facilities, Non-Profit & Academic Facilities |
| Procurement Model | Direct Capital Purchase, Leasing, Managed Equipment Services, Distributor/Third-Party Procurement |
Automated Breast Ultrasound Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Radiology AI Integration Opportunity Assessment |
|
| Screening Program Adoption Assessment |
|
| Breast Imaging Workflow Optimization Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the automated breast ultrasound market generate?
How much is the automated breast ultrasound industry expected to grow by 2036?
How is rising breast cancer prevalence influencing demand for automated breast ultrasound systems?
How are screening initiatives and AI advancements shaping adoption of automated breast ultrasound technologies?
Why does ABUS remain the dominant product in the automated breast ultrasound market?
Why is the Automated Breast Volume Scanner segment growing faster than other technologies?
Why does North America lead the automated breast ultrasound market?
What is driving Asia Pacific’s growth in this market?
What are the prominent companies operating in the automated breast ultrasound landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization